News
Curing Cholestatic Liver Disease After Cognitive Impairment
Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems.
There is presently no known cure...
News
3D COF Shows Good Hydrogen, CO2, And Methane Adsorption
In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c topology...
Industry Reports
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3...
Drug Research
EMA Advocates For Recall of Pholcodine Drugs From EU Market
PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as cold...
Drug Research
Regulations And Directive Revisions For Human Medicines
What changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end of 2022?
The current European Union...
Drug Research
Vaccines Europe Undertakes Its First Regulatory Evaluation
With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership.
The...
Drug Research
By 2028, Non-Vaccine mRNA Therapy Will Earn $2 Billion
A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA (mRNA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.